Journal of the National Comprehensive Cancer Network
ISSN:1540-1405

Journal of the National Comprehensive Cancer Network

J NATL COMPR CANC NE
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:偏慢,4-8周
新锐分区:医学2区
年发文量:141
影响因子:16.4
JCR分区:Q1

基本信息

JNCCN对NCCN肿瘤学临床实践指南®进行了更新,(征集的)综述文章阐述了指南建议、卫生服务研究和病例报告,突出了患者护理中的分子见解。JNCCN的愿景是通过作为NCCN临床实践指南信息的主要资源来推进NCCN的使命(NCCN指南®)、转化医学创新以及与肿瘤健康服务研究相关的科学研究,包括优质护理和价值、生物伦理学、比较和成本效益、公共政策、以及支持性护理和生存率干预性研究。
1540-1405SCIE/Scopus收录
16.4
15
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:ONCOLOGY
SCIE
Q1
17/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:ONCOLOGY
SCIE
Q1
17/328
88
141
2%-偏慢,4-8周-ONCOLOGY-
0.6%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
90.07%0.46%0.68%
CiteScore:24.70
SJR:5.514
SNIP:5.170
学科类别分区排名百分位
大类:Medicine
小类:Oncology
Q1
17 / 415

期刊高被引文献

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.0018
NCCN Guidelines Updates: Pancreatic Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5007
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.0002
NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5005
Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7070
NCCN Guidelines Updates: Management of Prostate Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5011
NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5014
Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7305
A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7104
NCCN Guidelines Updates: Management of Muscle-Invasive Bladder Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5017
Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7098
Advance Care Planning Improves Psychological Symptoms But Not Quality of Life and Preferred End-of-Life Care of Patients With Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7106
Revisiting Minimally Invasive Surgery in the Management of Early-Stage Cervical Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7263
PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7274
Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7082
Managing Pain in Patients and Survivors: Challenges Within the United States Opioid Crisis.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5010
Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7280
Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7306
Decreasing Use of Chemotherapy in Older Patients With Stage III Colon Cancer Irrespective of Comorbidities.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7287
Small Bowel Adenocarcinoma: Etiology, Presentation, and Molecular Alterations.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7344
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7079
Developments in Systemic Therapy for Soft Tissue and Bone Sarcomas.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5020
Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7086
Low Provider Knowledge Is Associated With Less Evidence-Based Lung Cancer Screening.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7101
Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7269
Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7297
Challenges With the 8th Edition of the AJCC Cancer Staging Manual for Breast, Testicular, and Head and Neck Cancers.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5015
Predictors of Locoregional Recurrence After Failure to Achieve Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7103
Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7281
Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7093
Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7286
State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7364
Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7325
Ovarian Clear Cell Carcinoma in Cowden Syndrome.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7065
Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7309
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7095
Impact of Incident Cancer on Short-Term Coronary Artery Disease-Related Healthcare Expenditures Among Medicare Beneficiaries.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7078
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7320
PD-1 Blockade in a Liver Transplant Recipient With Microsatellite Unstable Metastatic Colorectal Cancer and Hepatic Impairment.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7328
Therapeutic Advances in First-Line Management of Acute Myeloid Leukemia.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5031
Updates in Treatment Strategies for Hodgkin Lymphoma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5027
Digital Rectal Examination Remains a Key Prognostic Tool for Prostate Cancer: A National Cancer Database Review.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7278
New Biosimilar Approvals for Myeloid Growth Factors and Anemia.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5016
NCCN Guidelines Updates: Breast Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.5006
Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7298
Personalizing Precision Oncology: From Light Microscope to Molecular Microscope.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7330
Use of Imaging During Staging and Surveillance of Localized Colon Cancer in a Large Insured Population.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2019.7315
Orally Administered Cancer Therapy: Breaking Down Barriers to Adherence and Quality of Life.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7284
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7283
Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
来源期刊:Journal of the National Comprehensive Cancer Network : JNCCNDOI:10.6004/jnccn.2018.7085

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
2区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
ONCOLOGY 肿瘤学
3区